Good day, and welcome to the Acme United third quarter earnings results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone, and to withdraw your question, please press star then two. I would now like to turn the conference over to Mr. Walter Johnsen, Chairman and CEO. Please go ahead, sir.
Good afternoon. I'm Walter C. Johnsen, Chairman and CEO. With me is Paul Driscoll, our Chief Financial Officer, who will first read a safe harbor statement. Paul?
Forward-looking statements in this conference call, including, without limitation, statements related to the company's plans, strategies, objectives, expectations, intentions, and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties such as, among others, those arising as a result of the effects of the COVID-19 pandemic, including the ongoing economic downturn and the other risks and uncertainties described in our periodic filings with the Securities and Exchange Commission and our current earnings release.
Thank you, Paul. Our net sales in the third quarter of 2022 were $49.7 million compared to $47.9 million last year, an increase of 4%. Our net income was $63,000 compared to $2 million, and earnings per share were $0.02 compared to $0.50. In the second quarter of 2022, we had revenue growth of 27%, which we believe was due to forward purchasing by our customers to avoid supply chain disruptions. We also had catch-up shipments of $3.5 million-$4 million, which had been delayed by supply chain problems in the first quarter. For the year to date, revenues have increased 10%, and revenues have been lumpy but moving forward.
We anticipate revenues for 2022 to range from $190 million to $195 million, a slight decline from our earlier guidance of $200 million. The supply chain issues in the first six months of 2022 caused us to incur extraordinary shipping demurrage and freight costs. As you may know, the cost to deliver a container from Shanghai to Los Angeles increased rapidly, peaking at approximately $20,000 and more than double the prior year. We paid demurrage fees because the containers stayed at the ports longer than contracted, even though this was due to the ports' inability to access them. A shortage of truck drivers to deliver the goods and high fuel costs caused our freight to abnormally increase.
In total, we incurred approximately $4.4 million of extra expenses due to this array of problems. Our costs of inbound freight are included in our product costs, and we expense them as the inventory is sold. This resulted in $450,000 of extra supply chain costs in the first quarter of 2022, $1.3 million in the second quarter, and $1.3 million in the third quarter. There remains approximately $1.3 million, which we anticipate expensing over the next two quarters. Fortunately, the supply chain issues have substantially improved. The cost to ship a container across the Pacific has fallen to less than $10,000. We are not incurring demurrage fees from the ports, and the driver shortage has stabilized. We believe the extra supply chain costs are largely behind us.
We've implemented an extensive productivity and cost-saving initiative, including $600,000 in reduced selling expenses, $2.4 million in product cost savings, and $800,000 annually in lower labor costs. We have purchased new equipment to expand production at our Med-Nap facility and to gain new business at Spill Magic. We expect these cost savings and productivity improvements to generate over $5 million in savings, and we continue to add more. Some of the savings start in this quarter, but all are anticipated to flow in 2023. Taking a step back, like many other companies, we have had unexpected supply chain issues that came and went. They reduced a total of $4 million in pre-tax earnings. However, we see beyond that. We have an excellent first aid and medical business with strong recurring revenues from refill sales.
We have new placements in the retail and industrial markets for 2023 and a runway for continued growth. We have the largest global market share of scissors and shears, which benefits from the school, office, craft, industrial, and home end-users. We've gained new craft placement in 2023 at major mass market retailers, and we continue to gain in e-commerce. The same difficult environment we are in has also opened opportunities. For example, in September, we took over the sales of a small competitor of Safety Made by purchasing its inventory and intellectual property for $860,000. The annual revenues of this are forecast to be about $1.4 million with about $400,000 of EBITDA.
Although small, it represents the kind of opportunistic situations that may arise. In summary, we have in place the growth platform for 2023 and a $5 million cost savings and productivity plan that has been mostly implemented. We are confident that we will move beyond the supply chain issues to a much better year in 2023. I'll now turn the call to Paul.
Acme's net sales for the third quarter were $49.6 million compared to $47.9 million in 2021, an increase of 4%. Sales for the nine months ended September 30, 2022 were $149.7 million compared to $136.3 million in the same period in 2021, an increase of 10%. Net sales in the U.S. segment increased 4% in the third quarter. Sales in the second quarter of 2022 were impacted by certain customers making large purchases in anticipation of supply chain delays. Sales increased 12% for the nine months ended September 30, mainly due to market share gains in first aid and medical products and higher sales of Westcott products.
Net sales for Europe increased 13% on local currency for the quarter and 9% for the nine months ended September 30. The sales increase for both periods was mainly due to new customers in the office channel. Net sales in local currency for Canada increased 3% in the quarter and 5% for the year-to-date. Sales of first aid products grew mainly in the online business. Gross margin was 32% in the third quarter of 2022 compared to 35.5% in 2021. The year-to-date gross margin was 33% compared to 35.8% in 2021. The decline in both periods was primarily due to higher ocean freight and related transportation costs for imported goods. Also contributing to the decline were weaker currencies in Europe and Canada, where we purchase most of our inventory in U.S. dollars.
SG&A expenses for the third quarter of 2022 were $15 million, or 30% of sales, compared with $14 million or 29% of sales for the same period of 2021. SG&A expenses for the first 9 months of 2022 were $43 million or 29% of sales, compared with $39 million or 29% of sales in 2021. Included in other expense of $210,000 in the third quarter of 2022 was a foreign exchange loss of $170,000 related to revaluing U.S. dollar payables in our European business due to an 8% depreciation in the euro in the quarter. Interest expense for the third quarter of 2022 was $720,000 compared to $230,000 in the third quarter of 2021.
Interest expense for the nine mronths ended September 30 was $1.4 million compared to $670 thousand for the same period of 2021. The increase for both periods was due to higher debt and higher interest rates. Our overall average interest rate for the nine months in 2022 was 3.2% compared to 2% for the nine months in 2021. The overall average interest rate for the three months ended September 30, 2022 was 4.2% compared to 2% for the same period in 2021. Net income for the third quarter of 2022 was $64 thousand, or $0.02 per diluted share, compared to net income of $2 million or $0.50 per diluted share for the same period of 2021.
Net income for the nine months ended September 30 was $3.6 million or $0.96 per diluted share. Excluding the impact of the PPP loan forgiveness of $3.5 million, net income was $7.8 million or $1.97 per diluted share in the nine months ended September 30, 2021. The three and nine-month results were impacted by the exceptional supply chain costs and higher interest expense. The company's debt less cash on September 30, 2022 was $64 million compared to $38 million on September 30, 2021. During the 12-month period, we paid $11 million for the Safety Made acquisition, spent $1.8 million in dividends and repurchased $1.5 million of common stock.
During that period, inventory increased approximately $17 million, primarily due to anticipated growth in the business, higher costs, and purchasing additional safety stock to offset the impact of potential supply chain disruptions related to COVID-19. We expect inventory to decline by approximately $2 million by year-end.
Thank you, Paul. I will now open the call to questions.
Thank you. We will now begin the question-and-answer session. To ask a question, you may press star then one on your touchtone phone. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two. At this time, we'll pause momentarily to assemble our roster. Our first question will come from Chris Sakai with Singular Research. Please go ahead.
Yes, hi. I'm in for Jim Marrone. Just had a question regarding your reduction in SG&A. You know, how is this gonna affect headcount next quarter and in the year?
Well, we've trimmed our headcount in SG&A, and that was done around the middle of September. While there's still severance payments, that's done. Going forward, we generate savings.
Okay, thanks for that. I noticed there's a lot of currency exchange rate fluctuations. Does Acme United have any exchange rate hedges for their international sales?
We will sometimes lock in for large customer orders a forward contract against that purchase order. In this case, the kinds of declines that happened in the euro were beyond anything we would've normally hedged for. Of course, this relates to the substantial increases in U.S. rates and, frankly, the war in Ukraine, both of which were really not hedgeable.
Okay, thanks for that. Finally, for the increase in inventory, you know, how much of this is there any worry about inventory obsolescence or can you provide any color there?
Sure. Most of our inventory are items that don't change too much from year to year. Our school products are very, very consistent. Our office products are. In the first aid area, there's some products that have expiration dates, but we tend to keep those carefully managed, so there's not an excess of inventory there. In general, it's not like electronics or semiconductors or clothing where it's a fashion item. These are proprietary, but they're pretty much stable items without rapid changes in designs. We're quite comfortable with the inventory that we have.
Okay. Thanks, Walter.
Thank you, Chris.
Again, if you have a question, please press star then one. Our next question will come from Richard Dearnley with Longport Partners. Please go ahead.
Good afternoon.
Good afternoon, Dearnley.
At a guess, what if, you know, your inventories are up 36%, what proportion of that is price and which units?
Dick, it's approximately evenly split between what we would increase for growth, the costs and the safety stock that we put in place for potential supply chain disruptions.
No. It would be about even between the three?
Correct.
Oh. Oh, okay. Europe was only down 3% in dollars. You know, would seem like they're in a recession, and you know, who knows what, not to mention turmoil in Great Britain. What are you expecting out of them, or you know?
Well, our European business is facing some softness in sales. They are having a lot of inflation, and that's in part due to oil and gas. In part, it's the weakness of their currency. So they've got price increases that they're passing through with our products that are high, and it's very uncomfortable because the people there are under extreme pressure. It's not an easy environment in Europe. We've seen that at least sales in the last quarter were slightly up, so it hasn't fallen off a cliff. But it's been a very tough environment in Europe.
Right. Yeah. It would sure seem that way. The cost decrease estimated for 2023, the $5 million, is that independent of the $4.4 million of supply chain costs? I mean, I would
The answer to that is yes.
Yes.
They're additive.
Right.
The $1, the $4.4 were just expenses that we ran through and we're done with. The cost savings are an additional $5 million.
Right. It would seem like, of the four of supply chain, you'd get back, you know, as things normalize, assuming demand doesn't fall off a cliff, you get back a reasonable percentage of that on the other side, if you would.
Wherever that is.
Well, that's accurate. In the overall environment, there's a lot of inflation, so we're not counting on that in our numbers. Although it's true that the cost of some containers that we've got now are well under $10,000, some of them are as low as $4. You would pick up some savings there. There's still inflation throughout Asia, Europe and the U.S. It's really a combination of a lot of cost pressures. In this case, the freight will be working in our favor, we hope.
Right. On your slide eight, I was intrigued by the bullet point about product cost decreases opening up new business opportunities in medical and defense. Is that solely because your unit costs went down or what are you trying to say there? And that's-
Well, well, Dick, I don't know exactly what slide you're looking at because we don't have any slides in this presentation.
Oh.
In general, what I think we're referring to is in the Med-Nap business, where we're making alcohol wipes and alcohol prep pads. We are driving the cost down to be absolutely competitive and compelling in the world market so that when we get military or medical business, it's not just because we're U.S. made, but because we're the lowest cost producer. Some of the equipment that we're putting in there does a lot of automation, which helps to drive those costs down.
Great. Okay. Thank you.
Thank you.
The next question will come from Peter Sidoti with Sidoti & Company. Please go ahead.
Good afternoon, gentlemen.
Hello, Peter.
Just a quick question about cash flow from operations. It looks like you've been using cash this year for the first nine months, but I would assume that you'll start turning cash flow positive this year and into next year. Can you give me a handle on just, you know, what you expect to spend in capital spending and what your working capital should be next year needs?
Yeah. Paul, why don't you handle that one?
Well, most of the cash flow from operations is going, has been going towards inventory, and we're expecting to not grow inventory, in fact, to reduce inventory. We're gonna generate cash flow from reducing inventory. Capital expenditure, which has been averaging around $5 million a year, that will probably continue at a similar pace. The big change going forward is gonna be inventory, whereas it's been a negative drain. It'll be, you know, hopefully somewhat positive going forward.
As you generate that cash, how will you put it to use?
Well, I can tell you that the first thing is paying down debt.
Yeah, we'll pay down debt.
Yeah. Getting positioned for the next acquisition.
Okay. Thank you very much.
Thanks, Peter.
Again, if you have a question, please press Star then one. Our next question will come from Jeffrey Matthews with Ram Partners. Please go ahead.
Hi, Walter.
Hi, Jeff.
You were one of the first CEOs to highlight the disruption in the U.S. supply chain. Well, the global supply chain, really. That was several calls ago. Where do you see things now, in general versus the worst of it and versus where you'd like it to be?
Well, the wild card, of course, for people, for companies that import from China in particular, is that the vast majority of their population has not been vaccinated with Western vaccines. The fear is that it could possibly spread again as the weather gets cold in a serious way. Right now China is still continuing to be cautious. It's still pretty difficult to come into China for normal businessmen. The Chinese are very cautious about that, and rightly so, because of the exposure that the population has. If they get seriously sick from COVID, well, then all the inventory that we have right now will come in very handy. I'm not anticipating that.
I think the availability of Western vaccines, while maybe not being used right now, would certainly be available for China to vaccinate its population. That's the biggest risk I see in supply chain right now. If they stay healthy, the factories produce. As far as the shipping, there's now an overcapacity of container ships. They've been building for the last two years, and there's more of those. Containers themselves are, there's many more of them. Many are still in the wrong places, but the price to move them across the ocean has dropped substantially. In the West Coast ports, the ports like L.A. and Long Beach are pretty much back to normal. East Coast still has some congestion, but vastly different than six months ago.
Right. Great. Thanks and good luck.
Thank you.
This concludes our question and answer session. I would like to turn the conference back over to Mr. Walter Johnsen for any closing remarks. Please go ahead, sir.
I'd like to thank you for joining the call today. Just as an aside, the previous and former conference coordinator, the organization that we have used for a number of years did not have a schedule, and so we fired them. I'm very happy that we've now got a competent conference coordinator. We look forward to speaking to you again at the end of the fourth quarter. I also look forward to seeing some of you at the LD Micro conference next week. Thank you for joining us, and goodbye.
The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
Bye-bye.